28-05-2026 22:00 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 394.82
NSE Code AUROPHARMA
Dividend Yield % 0.28
Market Cap 826041.27
P/E 34.21
EPS 41.97
Face Value 1  
Description ( As On March 2026 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  13  283115075  48.75  283115075  
  Foreign Promoter  1  17833646  3.07  17833646  
  Total Promoter  14  300948721  51.82  300948721  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  41  103308668  17.79  103308668  
  FI/Bank/Insurance  23  29068035  5  29068035  
  Govt          
  FII          
  Other  679  106361390  18.32  106361390  
  Total Institutions  743  238738093  41.11  238738093  
 Non-Institution          
  Bodies Corporate  1739  3342743  0.58  3341633  
  Individuals          
  NRIs/OCBs  7890  2338088  0.4  2338028  
  Others  230912  35433978  6.1  34849548  
  Total Non-Institution  240541  41114809  7.08  40529209  
Total Non Promoter  241284  279852902  48.18  279267302  
          
  Depository Receipts          
          
Grand Total  241298  580801623  100  580216023  
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.